Article Details

Icosavax Closes $100 Million Series B Financing to Advance Bivalent RSV/hMPV Vaccine ...

Retrieved on: 2021-04-07 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Icosavax Closes $100 Million Series B Financing to Advance Bivalent RSV/hMPV Vaccine .... View article details on hiswai:

Excerpt

Icosavax's existing investors also participated, including Qiming Venture Partners USA, Adams Street Partners, Sanofi Ventures, and ND Capital.

Article found on: www.oaoa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up